MedPath

Effects of Nigella Sativa in Obese Wome

Phase 2
Conditions
Obesity.
Obesity due to excess calories
Registration Number
IRCT201106191197N10
Lead Sponsor
Vice Chancellor for research of Tabriz Uniersity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
82
Inclusion Criteria

women with 25-50 years old; Body Mass Index between 30 to 34.9 kg/m2; following no weight loss diet or any special diet during 6 months ago. Exclusion criteria: taking vitamin-mineral supplement during 3 months ago;taking anti-inflammatory medications, losing weight drugs, asprin and other anticoagulant medications; cardiovascular diseases, liver, kidney and tyroid disorders,type 1 or 2 diabetes; pregnancy and lactation; smoking

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anthropometric indices. Timepoint: Beginning and at the end of the intervention(after 2 months). Method of measurement: Height,weight,waist circumference,hip circumference mesearment.;Inflammatory factors. Timepoint: Beginning and at the end of the intervention( after 2 months). Method of measurement: Measurement of IL-6,TNF-a and hs-CRP with special kits.;Lipid profile. Timepoint: Begining and at the end of study(2 months). Method of measurement: Measurment of HDL-C,LDL-C,TG,TC with special kits.
Secondary Outcome Measures
NameTimeMethod
Frequency of adiponectin and PPAR gamma-2 genotypes. Timepoint: Begining of intervention. Method of measurement: PCR-RFLP.
© Copyright 2025. All Rights Reserved by MedPath